Goodwill of Enveric Biosciences, Inc. from 30 Sep 2015 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Enveric Biosciences, Inc. quarterly Goodwill in USD history and change rate from 30 Sep 2015 to 30 Sep 2023.
  • Enveric Biosciences, Inc. Goodwill for the quarter ending 30 Sep 2023 was $253,120, a 83% decline year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Enveric Biosciences, Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $253,120 -$1,215,269 -83% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $295,311 -$1,266,632 -81% 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $337,498 -$1,273,282 -79% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $379,686 -$1,207,948 -76% 31 Dec 2022 10-Q 13 Nov 2023 2023 Q3
Q3 2022 $1,468,389 -$7,593,538 -84% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $1,561,943 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $1,610,780 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $1,587,634 31 Dec 2021 10-K 26 Mar 2024 2023 FY
Q3 2021 $9,061,927 -$4,667,843 -34% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q3 2020 $13,729,770 $0 0% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $13,729,770 $0 0% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $13,729,770 $0 0% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 $13,729,770 $0 0% 31 Dec 2019 10-Q 16 Nov 2020 2020 Q3
Q3 2019 $13,729,770 -$8,168,553 -37% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $13,729,770 -$8,168,553 -37% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $13,729,770 -$8,168,553 -37% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 $13,729,770 -$8,168,553 -37% 31 Dec 2018 10-K/A 12 Aug 2020 2019 FY
Q3 2018 $21,898,323 +$11,756 +0.05% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 $21,898,323 +$11,756 +0.05% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 $21,898,323 +$18,751 +0.09% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 $21,898,323 +$4,809,247 +28% 31 Dec 2017 10-K 26 Mar 2019 2018 FY
Q3 2017 $21,886,567 +$4,507,536 +26% 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 $21,886,567 +$18,066,535 +473% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 $21,879,572 +$18,209,050 +496% 31 Mar 2017 10-Q/A 15 May 2017 2017 Q1
Q4 2016 $17,089,076 +$13,618,554 +392% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 $17,379,031 +$13,908,509 +401% 30 Sep 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 $3,820,032 30 Jun 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 $3,670,522 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 $3,470,522 31 Dec 2015 10-K/A 04 Apr 2017 2016 FY
Q3 2015 $3,470,522 30 Sep 2015 10-Q 23 Nov 2015 2016 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.